English
| dc.contributor.author | Arisoy, AS | |
| dc.contributor.author | Altinisik, B | |
| dc.contributor.author | Tünger, Ö | |
| dc.contributor.author | Kurutepe, S | |
| dc.contributor.author | Ispahi, Ç | |
| dc.date.accessioned | 2024-07-18T11:55:56Z | |
| dc.date.available | 2024-07-18T11:55:56Z | |
| dc.description.abstract | MMV MEDIEN & MEDIZIN VERLAGSGESELLSCHAFT MBH | |
| dc.identifier.uri | http://akademikarsiv.cbu.edu.tr:4000/handle/123456789/6590 | |
| dc.language.iso | Article | |
| dc.publisher | 0300-8126 | |
| dc.subject | Background: The aim of this study was to determine the prevalence of group B Streptococcus (GBS) colonization and to evaluate the antimicrobial resistance profile in women in the third trimester of pregnancy. Materials and Methods: A total of 310 pregnant women, referred in weeks 35 to 37 of gestation, were screened for GBS colonization during a 10-month period. Samples were collected from the vagina and the rectum. Results: The colonization rate was 10.6% and 22 women (66.7%) had both positive vaginal and rectal cultures. Rates of GBS colonization were significantly Lower in patients aged 24 years or older and in those with a third or Later pregnancy. None of the isolates were resistant to penicillin and ampicillin, whereas 21.2% and 9.1% showed resistance to erythromycin and clindamycin, respectively. Conclusion: Screening and antimicrobial susceptibility testing of GBS during pregnancy are important to guide appropiate therapy. | |
| dc.title | English | |
| dc.type | GBS INFECTION | |
| dc.type | PREVENTION | |
| dc.type | GUIDELINES |